Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust Abbott Laboratories Transaction History
Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust
- $7.77 Billion
- Q4 2024
A detailed history of Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust transactions in Abbott Laboratories stock. As of the latest transaction made, Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust holds 3,125,000 shares of ABT stock, worth $391 Million. This represents 4.55% of its overall portfolio holdings.
Number of Shares
3,125,000
Previous 3,125,000
-0.0%
Holding current value
$391 Million
Previous $356 Million
0.79%
% of portfolio
4.55%
Previous 4.76%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,204Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$21 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.59 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.22 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.66 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $219B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...